In TCGA cohort, PD-1 and Tim-3 mRNA expression levels were associated with the prognosis of CRC patients in terms of 5-year survival (P < 0.05, Figures 4(b) and 4(d)). Here, RPL17 is linked to colorectal carcinoma.